About Us.
Pideka is the first pharmaceutical grade cannabis indoor producer with EU-GMP standards in Latin America. Established in 2016 with legal permits to sale and export medicinal products worldwide.
Our cannabis, characterized by being the result of the highest quality cultivation and processing, is raw material as well as finished product.
Working hand to hand with the pharmaceutical industry, our ultimate goal and main driver is to offer patients with chronic or terminal illnesses an alternative treatment that promises to exponentially improve their physical and mental health, as well as their quality of life.
Hand-Crafted Cannabis.
We strive to grow the best pharma grade quality cannabis, from planting, trimming, manicuring, curing and packaging our complete process is done by hand to deliver rare, exotic and exclusively owned strains.
Genetics
Cultivation
Post Harvest
Lab Testing
Our History.
2019
BPA Certificate
Obtained our first certificate on Good Agricultural Practices (GAP/BPA) for Medical Cannabis.
2020
GMP Certificate
Became the first company in Latin America to obtain the certificate on Good Manufacturing Processes (GMP) for the pharma industry.
2021
EU-GMP Certificate
Our products are manufactured, packaged, and certified according to the EU-GMP standard for the European Union.
2022
ISO 9001
Obtained the International standard for quality management.
2023
ICann – GAP & GACP
Certified on IMC-GAP propagation and cultivation standards. The company can supply medical cannabis products to the Israeli market.
Our Competitive Advantages.
Indoor Model
Under state-of-the-art facilities, Pideka has the capacity to produce more than 7 tons of dry flower per year.Learn more
EU-GMP Standards
Pideka is the 1st company in the medical cannabis industry in Latin America that has obtained the EU-GMP Type 1 Certification.Learn more
Genetics
55 genetic Cultivars registered in the National Agricultural Insitute (ICA) of Colombia.Learn more
Tax Exemption
The only company in the industry with a tax exemption for 10 years, which represents a saving of more than USD 150 million in the next 5 years.
Learn more
Meet Our Team.
Borja Sanz de Madrid
Chief Executive Officer (CEO)
Sergio Ruiz
Chief Operations Officer (COO)
Camilo Cruz
Research & Development Officer (RDO)
Product Portfolio
